Readify

The 1960s methamphetamine epidemic

Beautiful Boy: A Father's Journey Through His Son's Addiction

The 1960s methamphetamine epidemic brought illicit speed into San Francisco and made its dangers visible in the Haight Ashbury, where doctors encountered a wave of emergencies, paranoia, and violence. In the book’s account, the first epidemic was both a neighborhood crisis and an early chapter in methamphetamine’s recurring national spread: the drug’s reach would later broaden, while the scale of its harm remained unevenly recognized and impossible to reduce to any one family’s story.

Emergence and Early Research

Before the 1960s, methamphetamine had already been used by military forces during World War II and sold in relatively mild formulations. Japan saw widespread use after 1941; by 1948, about five percent of people aged sixteen to twenty-five were using the drugs, and approximately fifty-five thousand people showed symptoms of what doctors called meth-induced psychosis. In the United States, the Food and Drug Administration classified methamphetamine as a controlled substance in 1951, requiring a prescription. These earlier episodes form a context for, rather than a simple explanation of, the illicit epidemic that followed.

The illegal speed craze reached the United States in the early 1960s. Its forms included crank, a pale yellow methamphetamine derivative that was snorted, and crystal meth, a purer form that could be injected or snorted. Illicit laboratories appeared in San Francisco in 1962, and speed spread through the Haight Ashbury. The local outbreak preceded what the book describes as the first national epidemic of the drug in the middle and late 1960s.

The Haight Ashbury Crisis

David Smith, who founded the Haight Ashbury Free Clinic, recalled a sharp contrast between the drug emergencies that came before methamphetamine and those that followed it. Earlier bad experiences with LSD tended to leave users comparatively mellow, in his account; methamphetamine instead brought neighborhood devastation, emergency-room visits, and deaths. He described the drug as ending the Summer of Love, puncturing the era’s optimistic image with a public-health crisis that clinicians could not ignore.

Smith’s observations began before he founded the clinic. While a student at the University of California Medical School, he saw overdoses of the new drug in the hospital emergency room and began clinical research into its effects. In experiments, rats given small doses died of massive seizures. Rats housed together died after smaller doses, and the behavior Smith observed suggested that methamphetamine could cause ordinary social cues to be misread as threats. The experiments offered a stark indication of the drug’s destructive potential, while his later work in the neighborhood brought him face to face with its human consequences.

In 1967, Smith left the university setting to work in the Haight. He encountered people using speed, staying awake, and becoming paranoid and dangerous. The following year, he issued the warning that speed kills. He also described so-called shoot-offs at the Crystal Palace, a bar, where users passed a needle among themselves and competed over speed of injection. Smith received early-morning calls about users in acute psychosis. Shared needles also contributed to a hepatitis C epidemic. The danger thus extended beyond the immediate effects of intoxication: the practices surrounding use created additional health risks.

A Recurring and Expanding Epidemic

The book stresses that methamphetamine use in the United States has waxed and waned since its first major wave. By the period it describes, experts considered the drug more potent and pervasive than before. Whereas earlier use had been concentrated in western cities, the later epidemic had spread into the Midwest, South, and East Coast. Its expansion into new regions also complicated recognition: the problem could grow in hospitals, rehabilitation facilities, and jails before its national extent was acknowledged in Washington.

The figures cited show both increasing treatment demand and a change in official assessments. From 1993 to 2005, annual admissions to rehabilitation for methamphetamine addiction rose from twenty-eight thousand to about one hundred and fifty thousand, more than fivefold. In 2006, the Substance Abuse and Mental Health Services Administration reported surging treatment admissions. A survey of five hundred local law-enforcement officials had already identified methamphetamine as their leading drug problem, ahead of cocaine and marijuana. Later that year, a larger survey of 3,400 drug-enforcement agencies found that 40 percent considered it their most significant drug problem, the first time a plurality had done so in that survey’s history.

The consequences described extend beyond treatment systems. Methamphetamine was associated with rising emergency-room appearances and crime in affected communities; officials in some places attributed increased murder rates to the drug. The book also reports high rates of spousal and child abuse in cities where methamphetamine predominated. These claims describe patterns reported across communities, not a forecast that every user or family will experience the same events. That distinction matters: broad trends establish the public-health stakes, but they cannot determine the course of a particular person’s illness or recovery.

Social Reach and the Limits of Explanation

The later epidemic crossed distinctions of class, race, education, geography, and intelligence. The book therefore resists treating methamphetamine addiction as the predictable result of one social background. The author considers whether privilege, poverty, schooling, or family circumstance might explain addiction, but points to people from widely different circumstances encountered in treatment and recovery settings. The account allows that nature and nurture may combine in ways that remain unknowable; it does not claim that a single factor explains who becomes addicted.

That uncertainty shapes the book’s use of statistics. Families may look to rates and percentages for a forecast, especially when weighing treatment after a relapse, but the author cautions that no outcome is guaranteed. People in recovery describe interventions that they later believed saved their lives; other families recount attempts that did not prevent a death. Statistics can convey that the adversary is formidable and guard against irrational optimism, but they cannot reveal which outcome awaits a given child. The epidemic’s history is therefore presented not as a formula for individual fate, but as evidence of scale alongside an insistence on uncertainty.

The public response to the family’s story further connects the historical account to the social experience of addiction. Hundreds of relatives wrote with compassion, shared grief, and recognition; some said that reading the account helped them feel less alone. Others criticized the decision to make the family’s experience public. That mix of judgment and solidarity echoes the stigma described in accounts of addiction, which can keep families silent even as the illness affects their lives. By placing private suffering within the history of a wider epidemic, the book shows how testimony can make hidden hardship recognizable without turning social trends into a complete explanation of any one family.

Related StoryFlow